BRPI1009221A2 - proteínas de fusão transcriptase reversa estabilizadas. - Google Patents

proteínas de fusão transcriptase reversa estabilizadas.

Info

Publication number
BRPI1009221A2
BRPI1009221A2 BRPI1009221A BRPI1009221A BRPI1009221A2 BR PI1009221 A2 BRPI1009221 A2 BR PI1009221A2 BR PI1009221 A BRPI1009221 A BR PI1009221A BR PI1009221 A BRPI1009221 A BR PI1009221A BR PI1009221 A2 BRPI1009221 A2 BR PI1009221A2
Authority
BR
Brazil
Prior art keywords
fusion proteins
reverse transcriptase
transcriptase fusion
stabilized reverse
stabilized
Prior art date
Application number
BRPI1009221A
Other languages
English (en)
Inventor
Alan M Lambowitz
Eman Ghanem
Sabine Mohr
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of BRPI1009221A2 publication Critical patent/BRPI1009221A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • C12N9/1276RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/30Nucleotides
    • C12P19/34Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y207/00Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07Nucleotidyltransferases (2.7.7)
    • C12Y207/07049RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/20Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/24Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a MBP (maltose binding protein)-tag

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BRPI1009221A 2009-03-04 2010-03-04 proteínas de fusão transcriptase reversa estabilizadas. BRPI1009221A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15733209P 2009-03-04 2009-03-04
PCT/US2010/026165 WO2010102085A2 (en) 2009-03-04 2010-03-04 Stabilized reverse transcriptase fusion proteins

Publications (1)

Publication Number Publication Date
BRPI1009221A2 true BRPI1009221A2 (pt) 2016-03-15

Family

ID=42710216

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1009221A BRPI1009221A2 (pt) 2009-03-04 2010-03-04 proteínas de fusão transcriptase reversa estabilizadas.

Country Status (11)

Country Link
US (4) US10113156B2 (pt)
EP (2) EP2403941B1 (pt)
JP (2) JP5882064B2 (pt)
CN (1) CN102421791A (pt)
AU (1) AU2010221284B2 (pt)
BR (1) BRPI1009221A2 (pt)
CA (1) CA2754476A1 (pt)
IL (1) IL214913A (pt)
MX (1) MX2011009205A (pt)
WO (1) WO2010102085A2 (pt)
ZA (1) ZA201107207B (pt)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101818126B1 (ko) * 2011-02-09 2018-01-15 (주)바이오니아 열안정성이 증가된 역전사효소
JP6068365B2 (ja) * 2011-02-23 2017-01-25 ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム Dna合成のためのテンプレートスイッチの使用
US9340799B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College MRNA-sensing switchable gRNAs
US9388430B2 (en) 2013-09-06 2016-07-12 President And Fellows Of Harvard College Cas9-recombinase fusion proteins and uses thereof
SG10202104041PA (en) 2015-10-23 2021-06-29 Harvard College Nucleobase editors and uses thereof
US10364420B2 (en) 2015-12-07 2019-07-30 Bio-Rad Laboratories, Inc Dimeric reverse transcriptase
KR20250103795A (ko) 2016-08-03 2025-07-07 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 아데노신 핵염기 편집제 및 그의 용도
US11661590B2 (en) 2016-08-09 2023-05-30 President And Fellows Of Harvard College Programmable CAS9-recombinase fusion proteins and uses thereof
WO2018039438A1 (en) 2016-08-24 2018-03-01 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
SG11201903089RA (en) 2016-10-14 2019-05-30 Harvard College Aav delivery of nucleobase editors
WO2018119359A1 (en) 2016-12-23 2018-06-28 President And Fellows Of Harvard College Editing of ccr5 receptor gene to protect against hiv infection
US11898179B2 (en) 2017-03-09 2024-02-13 President And Fellows Of Harvard College Suppression of pain by gene editing
EP3592381A1 (en) 2017-03-09 2020-01-15 President and Fellows of Harvard College Cancer vaccine
WO2018165629A1 (en) 2017-03-10 2018-09-13 President And Fellows Of Harvard College Cytosine to guanine base editor
WO2018176009A1 (en) 2017-03-23 2018-09-27 President And Fellows Of Harvard College Nucleobase editors comprising nucleic acid programmable dna binding proteins
WO2018209320A1 (en) 2017-05-12 2018-11-15 President And Fellows Of Harvard College Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
CN111801345A (zh) 2017-07-28 2020-10-20 哈佛大学的校长及成员们 使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物
EP3676376B1 (en) 2017-08-30 2025-01-15 President and Fellows of Harvard College High efficiency base editors comprising gam
US11352611B2 (en) 2017-10-03 2022-06-07 Board Of Regents, The University Of Texas System Non-LTR-retroelement reverse transcriptase and uses thereof
US11795443B2 (en) 2017-10-16 2023-10-24 The Broad Institute, Inc. Uses of adenosine base editors
WO2019118949A1 (en) 2017-12-15 2019-06-20 The Broad Institute, Inc. Systems and methods for predicting repair outcomes in genetic engineering
US12157760B2 (en) 2018-05-23 2024-12-03 The Broad Institute, Inc. Base editors and uses thereof
EP3820495A4 (en) 2018-07-09 2022-07-20 The Broad Institute Inc. RNA-PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES
WO2020092453A1 (en) 2018-10-29 2020-05-07 The Broad Institute, Inc. Nucleobase editors comprising geocas9 and uses thereof
US12351837B2 (en) 2019-01-23 2025-07-08 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
EP3942043A2 (en) 2019-03-19 2022-01-26 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
WO2020214842A1 (en) 2019-04-17 2020-10-22 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
CN114258398A (zh) 2019-06-13 2022-03-29 总医院公司 工程化的人内源性病毒样颗粒及使用其递送至细胞的方法
US12435330B2 (en) 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
US20230072235A1 (en) * 2020-02-17 2023-03-09 Leadxpro Ag Pro-macrobodies for the enhancement of structure research
EP4114937A4 (en) 2020-03-04 2024-09-04 Flagship Pioneering Innovations VI, LLC METHODS AND COMPOSITIONS FOR MODULATING A GENOME
BR112022022603A2 (pt) 2020-05-08 2023-01-17 Broad Inst Inc Métodos e composições para edição simultânea de ambas as fitas de sequência alvo de nucleotídeos de fita dupla
CN116670154A (zh) 2020-07-24 2023-08-29 总医院公司 增强的病毒样颗粒及使用其递送至细胞的方法
JP2023543803A (ja) 2020-09-24 2023-10-18 ザ ブロード インスティテュート,インコーポレーテッド プライム編集ガイドrna、その組成物、及びその使用方法
EP4274894A2 (en) 2021-01-11 2023-11-15 The Broad Institute, Inc. Prime editor variants, constructs, and methods for enhancing prime editing efficiency and precision
JP2024530487A (ja) 2021-08-06 2024-08-21 ザ ブロード インスティテュート,インコーポレーテッド 改善されたプライムエディターおよび使用方法
EP4707407A3 (en) * 2021-08-17 2026-05-20 New England Biolabs Inc REVERSE TRANSCRIPTION BY CIRCULAR ROLLING CIRCLE OF RNA
KR20260037664A (ko) 2021-09-08 2026-03-18 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 게놈을 조절하기 위한 방법 및 조성물
WO2023076898A1 (en) 2021-10-25 2023-05-04 The Broad Institute, Inc. Methods and compositions for editing a genome with prime editing and a recombinase
US20250064979A1 (en) 2021-12-03 2025-02-27 The Broad Institute, Inc. Self-assembling virus-like particles for delivery of prime editors and methods of making and using same
WO2023205687A1 (en) 2022-04-20 2023-10-26 The Broad Institute, Inc. Improved prime editing methods and compositions
WO2023240137A1 (en) 2022-06-08 2023-12-14 The Board Institute, Inc. Evolved cas14a1 variants, compositions, and methods of making and using same in genome editing
WO2024077267A1 (en) 2022-10-07 2024-04-11 The Broad Institute, Inc. Prime editing methods and compositions for treating triplet repeat disorders
EP4619515A1 (en) 2022-11-17 2025-09-24 The Broad Institute, Inc. Prime editor delivery by aav
WO2024168147A2 (en) 2023-02-09 2024-08-15 The Broad Institute, Inc. Evolved recombinases for editing a genome in combination with prime editing
WO2024206125A1 (en) 2023-03-24 2024-10-03 The Broad Institute, Inc. Use of prime editing for treating sickle cell disease
AU2024357861A1 (en) 2023-10-12 2026-04-23 Renagade Therapeutics Management Inc. Nickase-retron template-based precision editing system and methods of use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5322770A (en) 1989-12-22 1994-06-21 Hoffman-Laroche Inc. Reverse transcription with thermostable DNA polymerases - high temperature reverse transcription
US5643758A (en) 1987-03-10 1997-07-01 New England Biolabs, Inc. Production and purification of a protein fused to a binding protein
US5654176A (en) 1987-05-28 1997-08-05 Amrad Corporation Limited Fusion proteins containing glutathione-s-transferase
US5736373A (en) * 1996-09-23 1998-04-07 Becton, Dickinson And Company Thermostable DNA polymerase from Bacillus pallidus
US7001745B1 (en) 1998-09-30 2006-02-21 New England Biolabs, Inc. Intein mediated peptide ligation
US6436677B1 (en) * 2000-03-02 2002-08-20 Promega Corporation Method of reverse transcription
US6627424B1 (en) * 2000-05-26 2003-09-30 Mj Bioworks, Inc. Nucleic acid modifying enzymes
WO2003008454A2 (en) 2001-07-18 2003-01-30 Merck Patent Gmbh Glycoprotein vi fusion proteins
US7670807B2 (en) * 2004-03-10 2010-03-02 East Tennessee State Univ. Research Foundation RNA-dependent DNA polymerase from Geobacillus stearothermophilus
US7935509B2 (en) * 2004-08-13 2011-05-03 New England Biolabs, Inc. Intracellular production of a nuclease

Also Published As

Publication number Publication date
EP2403941B1 (en) 2018-10-03
CN102421791A (zh) 2012-04-18
JP2015193666A (ja) 2015-11-05
EP3415621A1 (en) 2018-12-19
US20160289652A1 (en) 2016-10-06
ZA201107207B (en) 2012-12-27
IL214913A0 (en) 2011-11-30
IL214913A (en) 2017-06-29
US20180340158A1 (en) 2018-11-29
CA2754476A1 (en) 2010-09-10
US10858636B2 (en) 2020-12-08
WO2010102085A3 (en) 2010-11-18
US10113156B2 (en) 2018-10-30
US20180346890A1 (en) 2018-12-06
JP2012519489A (ja) 2012-08-30
US10150955B2 (en) 2018-12-11
WO2010102085A2 (en) 2010-09-10
MX2011009205A (es) 2011-09-30
WO2010102085A4 (en) 2011-01-06
EP2403941A4 (en) 2012-09-05
AU2010221284B2 (en) 2015-10-01
JP5882064B2 (ja) 2016-03-09
AU2010221284A1 (en) 2011-10-27
EP2403941A2 (en) 2012-01-11
US20120009630A1 (en) 2012-01-12

Similar Documents

Publication Publication Date Title
EP2403941A4 (en) Stabilized reverse transcriptase fusion proteins
BRPI0820114A2 (pt) Engenharia de proteínas enzimaticamente suscetíveis
BRPI1011134A2 (pt) turbomáquina.
BRPI1010653A2 (pt) refrigerador.
CL2007002227S1 (es) Botella.
DK3118221T3 (da) Proteiner
EP2406388A4 (en) OX40 / TRAIL-FUSION PROTEIN
BR112012000281A2 (pt) proteína quimérica.
CL2008001030S1 (es) Botella.
IT1396487B1 (it) Convogliatore.
CL2008000591S1 (es) Botella.
DK2442870T3 (da) Pyrazinooxazepin-derivater.
BRPI1016192A2 (pt) derivados de soxazol.
CL2007002937S1 (es) Botella.
NL1036027C (nl) Afwatering.
BR112012014495A2 (pt) cosmético de autonivelamento.
BRPI1014244A2 (pt) composto de polipropileno-talco estabilizado.
IT1396642B1 (it) Statore.
FR2943510B1 (fr) Ombrelle.
ES1066333Y (es) Reloj de pulsera.
FR2918847B1 (fr) Kimono.
FR2935263B1 (fr) Cotyle prothetique articulaire.
FR2946591B1 (fr) Sur-tapis eclairant.
IT1396118B1 (it) Composizione dolcificante.
DK2219663T3 (da) Revers-protein

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.